These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6352770)

  • 1. Behçet's disease leucocyte inhibitory factor (LIF) in response to skin extract.
    Gilhar A; Haim S; Wolf V; Golan D
    J Dermatol; 1983 Apr; 10(2):185-6. PubMed ID: 6352770
    [No Abstract]   [Full Text] [Related]  

  • 2. Leucocyte migration inhibition in Behçet's disease.
    Haim S; Gilhar A; Mekori T; Segal R
    Dermatologica; 1979; 159(4):302-6. PubMed ID: 478067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental studies on tuberculin hypersensitivity--immunological significance of leucocyte migration inhibitory factor (LIF) and macrophage migration inhibitory factor (MIF) (author's transl)].
    Matsui Y; Oshima S
    Kekkaku; 1979 Jun; 54(6):331-44. PubMed ID: 388018
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of lymphokines in delayed-type hypersensitivity reactions.
    Geczy CL
    Springer Semin Immunopathol; 1984; 7(4):321-46. PubMed ID: 6395409
    [No Abstract]   [Full Text] [Related]  

  • 5. Leucocyte migration inhibition by tumour-associated antigens in human bladder carcinoma.
    Meleady DF; Butler MR; Greally JF; Mullins GM
    Ir J Med Sci; 1980 Oct; 149(10):391-400. PubMed ID: 7014519
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of in vitro irradiation upon LIF productions by ConA stimulated mononuclear cells.
    Sandru G; Veraguth P
    Int J Radiat Oncol Biol Phys; 1981 Dec; 7(12):1679-83. PubMed ID: 6460724
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
    Sugiura S; Sanefuji M; Ohno S
    Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Leukocyte migration inhibition evoked by Epstein Barr virus antigen. I. Immune response in healthy donors].
    Szigeti R; Klein G; Luka J; Volsky DJ
    Orv Hetil; 1981 Sep; 122(38):2327-31. PubMed ID: 6273776
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease--a multicenter study. The Behcet's Disease Research Committee of Japan.
    J Rheumatol; 1989 Apr; 16(4):506-11. PubMed ID: 2664172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin hyperreactivity response (pathergy) in Behçet's disease: usefulness of direct immunofluorescence.
    Wechsler J; Wechsler B; Revuz J; Godeau P
    J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):329-30. PubMed ID: 2212137
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of uraemic "middle-sized molecules" on T lymphocyte functions.
    Kálmán K; Löcsey L; Hauck M; Leövey A
    Int Urol Nephrol; 1980; 12(4):367-74. PubMed ID: 6763010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of gastric cancer patients in leucocyte migration inhibition tests to 3M KCl extracts from gastric tumor.
    Kojima O; Oh A; Kitagawa N; Uehara Y; Nishioka B; Fujita Y; Majima S
    Jpn J Surg; 1981; 11(6):413-21. PubMed ID: 7035728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of leukocyte migration in newborns infants and adults by bovine albumin and PPD].
    Hashimoto-Yáñez B; García-Tamayo F
    Bol Med Hosp Infant Mex; 1983 Jan; 40(1):17-22. PubMed ID: 6338886
    [No Abstract]   [Full Text] [Related]  

  • 14. Further purification of neutrophil migration inhibition factor from T lymphocytes (NIF-T): evidence that NIF-T and leukocyte inhibitory factor (LIF) are immunologically distinct.
    Weisbart RH; Chan G; Spolter L; Golde DW
    Clin Immunol Immunopathol; 1984 Sep; 32(3):269-74. PubMed ID: 6380843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome.
    Mor F; Weinberger A; Cohen IR
    Eur J Immunol; 2002 Feb; 32(2):356-65. PubMed ID: 11807775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo leucocyte migration in Behçet's syndrome.
    Efthimiou J; Addison IE; Johnson BV
    Ann Rheum Dis; 1989 Mar; 48(3):206-10. PubMed ID: 2649027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of the functional activity of lymphocytes in the pathogenesis of pregnancy nephropathy].
    Gavrilenko AS; Zlatovratskaia TV
    Akush Ginekol (Mosk); 1985 Jun; (6):42-3. PubMed ID: 2932014
    [No Abstract]   [Full Text] [Related]  

  • 18. Von Willebrand factor in Behçet's syndrome.
    Yazici H; Hekim N; Ozbakir F; Yurdakul S; Tüzün Y; Pazarli H; Müftüoğlu A
    J Rheumatol; 1987 Apr; 14(2):305-6. PubMed ID: 3496454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactoferrin stimulates the production of leucocyte migration inhibitory factor by human peripheral mononuclear leucocytes.
    Kijlstra A; Broersma L
    Clin Exp Immunol; 1984 Feb; 55(2):459-64. PubMed ID: 6365377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphocyte subsets in erythema nodosum-like skin lesions from patients with Behçet's disease].
    Yamana S; Jones L; Aoi K; Ishibe Y; Shimamoto T; Aoyama T
    Ryumachi; 1985 Nov; 25(5):344-7. PubMed ID: 3832477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.